These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6245002)

  • 1. Concentration and purification of poliovirus by immune adsorption on immobilized antibodies.
    van der Marel P; van Wezel AL; Hazendonk AG; Kooistra A
    Dev Biol Stand; 1980; 46():267-73. PubMed ID: 6245002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratypic differentiation of poliovirus strains by enzyme-linked immunosorbent assay (ELISA): poliovirus type 1.
    Glikmann G; Moynihan M; Petersen I; Vestergaard BF
    Dev Biol Stand; 1983; 55():199-208. PubMed ID: 6203794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-linked immunosorbent assay for detection of poliovirus antigen and antibody.
    Moynihan M; Ladefoged P; Mathiesen L
    Dev Biol Stand; 1980; 46():203-6. PubMed ID: 6244998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale concentration and purification of virus suspension from microcarrier culture for the preparation of inactivated virus vaccines.
    van Wezel AL; van Herwaarden JA; van de Heuvel-de Rijk EW
    Dev Biol Stand; 1979; 42():65-9. PubMed ID: 223923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains.
    Tano Y; Shimizu H; Martin J; Nishimura Y; Simizu B; Miyamura T
    Vaccine; 2007 Oct; 25(41):7041-6. PubMed ID: 17825459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
    Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
    J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameters for differentiating vaccine-derived and wild poliovirus strains.
    Nakano JH; Hatch MH; Thieme ML; Nottay B
    Prog Med Virol; 1978; 24():178-206. PubMed ID: 212784
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
    Rezapkin G; Martin J; Chumakov K
    Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis virus D-antigen.
    Souvras M; Montagnon B; Fanget B; van Wezel AL; Hazendonk AG
    Dev Biol Stand; 1980; 46():197-202. PubMed ID: 6244997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).
    Rezapkin G; Dragunsky E; Chumakov K
    Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-antigen determination in polio vaccine production: comparison of gel diffusion and ELISA methods.
    van der Marel P; Hazendonk AG; van Wezel AL
    Dev Biol Stand; 1981; 47():101-8. PubMed ID: 6262140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress with inactivated poliovirus vaccines derived from the Sabin strains.
    Doi Y; Abe S; Yamamoto H; Horie H; Ohyama H; Satoh K; Tano Y; Ota Y; Miyazawa M; Wakabayashi K; Hashizume S
    Dev Biol (Basel); 2001; 105():163-9. PubMed ID: 11763324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of elution marker for the intratypic characterization of poliovirus strains.
    Szöllõsy E; Mucsi I; Pálmai M
    Acta Microbiol Acad Sci Hung; 1976; 23(4):301-8. PubMed ID: 193364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current advances in viral diagnostic technology applicable to polio vaccination and diagnosis.
    Chernesky MA
    Rev Infect Dis; 1984; 6 Suppl 2():S525-7. PubMed ID: 6330851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity status to polioviruses among non-European union immigrants in Veneto Region (North-East Italy).
    Trivello R; Ngatchu T; Marin V; Moretti G; Malatesta R; Maini P; Moschen ME; Baldo V; De Marzi L; Majori S; Puppo A; Renzulli G
    Ann Clin Lab Sci; 1996; 26(2):154-9. PubMed ID: 8852425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
    Yang C; Shi H; Zhou J; Liang Y; Xu H
    Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.